perflutren has been researched along with Hemorrhage, Retinal in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.44) | 18.7374 |
1990's | 4 (9.76) | 18.2507 |
2000's | 18 (43.90) | 29.6817 |
2010's | 17 (41.46) | 24.3611 |
2020's | 1 (2.44) | 2.80 |
Authors | Studies |
---|---|
Lee, K; Park, YG; Park, YH | 1 |
Fujikawa, M; Gomi, F; Kakinoki, M; Kawamura, H; Miyake, T; Ohji, M; Sakaguchi, H; Sawada, O; Sawada, T | 1 |
Basu, S; Das, T; Nayak, S; Padhi, TR | 1 |
Chang, W; Garg, SJ; Gupta, SA; Ho, AC; Hsu, J; Maturi, R; Regillo, CD; Sivalingam, A | 1 |
Cho, HJ; Han, JI; Kim, HS; Kim, JH; Kim, JW; Koh, KM; Lee, TG; Lew, YJ | 1 |
Byeon, SH; Lee, JM; Shin, JY | 1 |
Ostheimer, TA; Rezaei, KA | 1 |
Byeon, SH; Choi, HJ; Choi, M; Chung, B; Lee, J; Shin, JY | 1 |
Cereda, MG; de Jong, JH; Faridpooya, K; van Meurs, JC; van Velthoven, ME; van Zeeburg, EJ; Vermeer, KA | 1 |
Barr, CC; Fassbender, JM; Schaal, S; Sherman, MP | 1 |
Kitagawa, Y; Mori, R; Shimada, H; Tanaka, K; Yuzawa, M | 1 |
Bindra, MS; de Silva, SR | 1 |
Kim, SH; Kwon, OW; Lee, JP; Park, JS; You, YS | 1 |
Hong, MC; Kung, YH; Sheu, SJ; Wu, TT | 1 |
Hong, MC; Kung, YH; Wu, TT | 1 |
Hesgaard, HB; la Cour, M; Torkashvand, M | 1 |
Basia, A; Ratra, D | 1 |
Jackson, TL; Liazos, E; McHugh, D; Papavasileiou, E; Steel, DH | 1 |
Hesse, L; Schulze, SD | 1 |
Borthwick, JH; Hart, RH; McGeorge, AJ; Vote, BJ; Worsley, DR | 1 |
Borrillo, JL; Regillo, CD; Tennant, MT | 1 |
Elias, A; Giridhar, A; Mahesh, G; Saikumar, SJ | 1 |
Buttery, R; Polkinghorne, PJ; Vote, BJ | 1 |
Kittantong, A; Ratanasukon, M | 1 |
Sheu, SJ; Wu, TT | 1 |
Chan, WM; Lai, TY; Lam, DS; Li, H; Liu, DT; Tong, JP | 1 |
Moshfeghi, DM; Ou, JI; Sears, JE; Tawansy, K | 1 |
Axer-Siegel, R; Ehrlich, R; Ron, Y; Rosenblatt, I; Weinberger, D | 1 |
Bhat, S; Elias, A; Giridhar, A; Gopalakrishan, M; N, S; Saikumar, SJ | 1 |
Chamberlain, M; Chen, CY; Chiu, D; Heriot, WJ; Hooper, C; Karia, N | 1 |
Chen, MS; Fang, IM; Lin, YC; Yang, CH; Yang, CM | 1 |
Kreissig, I; Lincoff, H; Stopa, M; Uram, D | 1 |
Ferrone, PJ; Lewis, H; Trese, MT | 1 |
Hayashi, A; Lewis, JM; Ohji, M; Saito, Y; Tano, Y | 1 |
Hesse, L; Kroll, P; Schmidt, J | 1 |
Blodi, BA; Elner, SG; Hassan, AS; Johnson, MW; Poliner, LS; Regillo, CD; Schneiderman, TE; Tornambe, PE | 1 |
Heller, G; Hesse, L; Kroll, P; Schroeder, B | 1 |
Blodi, BA; Chandra, SR; Handwerger, BA; Olsen, TW; Stevens, TS | 1 |
Kim, SH; Koh, HJ; Kwon, OW; Lee, SC | 1 |
Hejny, C; Sternberg, P | 1 |
Algvere, P; Hallnäs, K; Palmqvist, BM | 1 |
1 review(s) available for perflutren and Hemorrhage, Retinal
Article | Year |
---|---|
Management of submacular hemorrhage.
Topics: Fibrinolytic Agents; Fluorocarbons; Humans; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitrectomy | 2002 |
2 trial(s) available for perflutren and Hemorrhage, Retinal
Article | Year |
---|---|
INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study.
Topics: Acute Disease; Combined Modality Therapy; Endotamponade; Fibrinolytic Agents; Fluorocarbons; Humans; Injections, Intraocular; Intravitreal Injections; Prospective Studies; Recombinant Proteins; Retinal Hemorrhage; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Vitrectomy; Wet Macular Degeneration | 2016 |
Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aneurysm; Eye Injuries; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Injections; Macula Lutea; Macular Degeneration; Male; Middle Aged; Postoperative Complications; Prone Position; Retinal Hemorrhage; Retinal Vessels; Retrospective Studies; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 1999 |
38 other study(ies) available for perflutren and Hemorrhage, Retinal
Article | Year |
---|---|
VISUAL PROGNOSIS AFTER PNEUMATIC DISPLACEMENT OF SUBMACULAR HEMORRHAGE ACCORDING TO AGE-RELATED MACULAR DEGENERATION SUBTYPES.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Endotamponade; Female; Fluorescein Angiography; Fluorocarbons; Humans; Intravitreal Injections; Male; Middle Aged; Prognosis; Retinal Hemorrhage; Retrospective Studies; Supine Position; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2020 |
Comparison of pneumatic displacement for submacular hemorrhages with gas alone and gas plus tissue plasminogen activator.
Topics: Aged; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Intravitreal Injections; Male; Pressure; Retinal Hemorrhage; Retrospective Studies; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Visual Analog Scale | 2013 |
Pneumatic displacement and intra-vitreal bevacizumab in management of sub-retinal and sub-retinal pigment epithelial hemorrhage at macula in polypoidal choroidal vasculopathy (PCV): rationale and outcome.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid Diseases; Combined Modality Therapy; Female; Fluorocarbons; Humans; Intravitreal Injections; Male; Middle Aged; Peripheral Vascular Diseases; Pressure; Retinal Hemorrhage; Retinal Pigment Epithelium; Treatment Outcome | 2015 |
Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Air; Angiogenesis Inhibitors; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Humans; Injections, Intraocular; Male; Middle Aged; Prone Position; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Wet Macular Degeneration | 2014 |
Intravitreal ranibizumab injections with and without pneumatic displacement for treating submacular hemorrhage secondary to neovascular age-related macular degeneration.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Coloring Agents; Combined Modality Therapy; Endotamponade; Female; Fluorescein Angiography; Fluorocarbons; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
Anti-vascular endothelial growth factor with or without pneumatic displacement for submacular hemorrhage.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Endotamponade; Female; Fluorescein Angiography; Fluorocarbons; Follow-Up Studies; Humans; Intravitreal Injections; Male; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
PNEUMATIC DISPLACEMENT AS A TREATMENT OF TRAUMATIC MACULAR HOLE WITH SUBMACULAR HEMORRHAGE.
Topics: Endotamponade; Eye Injuries; Fluorocarbons; Humans; Intravitreal Injections; Male; Retinal Hemorrhage; Retinal Perforations; Treatment Outcome; Young Adult | 2016 |
Anti-Vascular Endothelial Growth Factor with Gas for Submacular Hemorrhage.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Combined Modality Therapy; Endotamponade; Female; Fluorescein Angiography; Fluorocarbons; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
Topics: Aged; Aged, 80 and over; Endotamponade; Exudates and Transudates; Female; Fibrinolytic Agents; Fluorocarbons; Fovea Centralis; Humans; Intravitreal Injections; Male; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tertiary Care Centers; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Vitrectomy; Wet Macular Degeneration | 2016 |
Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Humans; Intravitreal Injections; Male; Middle Aged; Polyps; Prone Position; Prospective Studies; Ranibizumab; Retinal Hemorrhage; Tissue Plasminogen Activator; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2016 |
Early treatment of acute submacular haemorrhage secondary to wet AMD using intravitreal tissue plasminogen activator, C3F8, and an anti-VEGF agent.
Topics: Acute Disease; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Endotamponade; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Intravitreal Injections; Male; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Secondary Prevention; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2016 |
Management of Acute Submacular Hemorrhage with Intravitreal Injection of Tenecteplase, Anti-vascular Endothelial Growth Factor and Gas.
Topics: Acute Disease; Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Follow-Up Studies; Fundus Oculi; Humans; Intravitreal Injections; Macula Lutea; Male; Middle Aged; Retinal Hemorrhage; Retrospective Studies; Tenecteplase; Tissue Plasminogen Activator; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Prone Position; Retinal Hemorrhage; Retrospective Studies; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body; Young Adult | 2010 |
Vitreous hemorrhage complicating intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Humans; Indocyanine Green; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Retinal Hemorrhage; Retrospective Studies; Risk Factors; Tissue Plasminogen Activator; Visual Acuity; Vitrectomy; Vitreous Hemorrhage; Young Adult | 2011 |
Failure to detect an effect of pneumatic displacement in the management of submacular haemorrhage secondary to age-related macular degeneration: a retrospective case series.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Endotamponade; Female; Fluorescein Angiography; Fluorocarbons; Humans; Intravitreal Injections; Macular Degeneration; Male; Prone Position; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2012 |
Intravitreous tissue plasminogen activator with pneumatic displacement in submacular hemorrhage.
Topics: Choroid Diseases; Coloring Agents; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Humans; Indocyanine Green; Intravitreal Injections; Middle Aged; Polyps; Retinal Hemorrhage; Supine Position; Tissue Plasminogen Activator | 2012 |
Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid Diseases; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Prone Position; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2013 |
Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Middle Aged; Prone Position; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitrectomy; Vitreous Body | 2002 |
Loss of vision caused by expansion of intraocular perfluoropropane (C(3)F(8)) gas during nitrous oxide anesthesia.
Topics: Aged; Aged, 80 and over; Anesthesia, General; Anesthetics, Inhalation; Blindness; Drug Interactions; Fluorocarbons; Humans; Intraocular Pressure; Male; Nitrous Oxide; Ocular Hypertension; Retinal Artery Occlusion; Retinal Detachment; Retinal Hemorrhage; Retinal Perforations; Visual Acuity; Vitrectomy | 2002 |
Intravitreal gas for submacular haemorrhage.
Topics: Female; Fluorescein Angiography; Fluorocarbons; Humans; Injections; Macula Lutea; Middle Aged; Prone Position; Retinal Hemorrhage; Vision Disorders; Vitreous Body | 2003 |
Endophthalmitis after intravitreal injection of frozen preprepared tissue plasminogen activator (tPA) for pneumatic displacement of submacular hemorrhage.
Topics: Aged; Cryopreservation; Drug Contamination; Endophthalmitis; Eye Infections, Bacterial; Female; Fluorocarbons; Gram-Positive Bacterial Infections; Humans; Injections; Propionibacterium acnes; Retinal Hemorrhage; Streptococcus; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitreous Body | 2004 |
Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular haemorrhage in Thais.
Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Fluorocarbons; Follow-Up Studies; Gases; Humans; Macular Degeneration; Middle Aged; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Thailand; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity | 2005 |
Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage secondary to retinal artery macroaneurysm.
Topics: Aged; Aged, 80 and over; Aneurysm; Combined Modality Therapy; Female; Fluorescein Angiography; Fluorocarbons; Humans; Injections; Male; Middle Aged; Plasminogen Activators; Prone Position; Retinal Artery; Retinal Hemorrhage; Retrospective Studies; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 2005 |
Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up.
Topics: Choroid; Choroid Diseases; Combined Modality Therapy; Female; Fluorescein Angiography; Fluorocarbons; Follow-Up Studies; Humans; Indocyanine Green; Injections; Male; Middle Aged; Peripheral Vascular Diseases; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Retinal Hemorrhage; Treatment Outcome; Verteporfin; Visual Acuity | 2005 |
Macular hole in the shaken baby syndrome.
Topics: Fluorocarbons; Humans; Infant; Male; Retinal Hemorrhage; Retinal Perforations; Shaken Baby Syndrome; Silicone Oils; Vitrectomy; Vitreous Hemorrhage | 2006 |
Pneumatic displacement of submacular hemorrhage due to age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Female; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Pressure; Prone Position; Retinal Hemorrhage; Sulfur Hexafluoride; Time Factors; Visual Acuity | 2007 |
Pneumatic displacement of submacular hemorrhage: safety, efficacy, and patient selection.
Topics: Adult; Aged; Female; Fluorocarbons; Humans; Injections; Male; Middle Aged; Patient Selection; Pressure; Prone Position; Prospective Studies; Retinal Hemorrhage; Treatment Outcome; Visual Acuity; Vitreous Body | 2007 |
Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas.
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Injections; Intraoperative Complications; Male; Middle Aged; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 2007 |
Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorocarbons; Gases; Humans; Macular Degeneration; Male; Middle Aged; Prognosis; Recombinant Proteins; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 2009 |
A 40 degrees gaze down position for pneumatic displacement of submacular hemorrhage: clinical application and results.
Topics: Fluorocarbons; Gravitation; Humans; Prone Position; Retinal Hemorrhage; Tomography, Optical Coherence; Visual Acuity | 2008 |
Vitreoretinal surgery for complications of congenital retinoschisis.
Topics: Adolescent; Child; Child, Preschool; Eye Diseases, Hereditary; Female; Fluorocarbons; Follow-Up Studies; Humans; Infant; Laser Coagulation; Male; Retinal Detachment; Retinal Diseases; Retinal Hemorrhage; Visual Acuity; Visual Fields; Vitrectomy; Vitreous Hemorrhage | 1997 |
Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator.
Topics: Aged; Aneurysm, Ruptured; Female; Fluorocarbons; Fundus Oculi; Humans; Macular Degeneration; Male; Middle Aged; Prone Position; Retinal Artery; Retinal Detachment; Retinal Hemorrhage; Tissue Plasminogen Activator; Visual Acuity; Vitrectomy; Vitreous Body; Vitreous Hemorrhage | 1998 |
Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas.
Topics: Acute Disease; Aged; Aged, 80 and over; Electroretinography; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Follow-Up Studies; Fundus Oculi; Humans; Injections; Macular Degeneration; Male; Middle Aged; Recombinant Proteins; Retinal Hemorrhage; Tissue Plasminogen Activator; Treatment Outcome; Vitreous Body | 1999 |
Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage.
Topics: Acute Disease; Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Middle Aged; Retina; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 2000 |
Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Humans; Indocyanine Green; Injections; Macula Lutea; Macular Degeneration; Male; Prone Position; Retinal Hemorrhage; Retrospective Studies; Safety; Thrombolytic Therapy; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 2001 |
Treatment of subhyaloid haemorrhage with intravitreal tissue plasminogen activator and C3F8 gas injection.
Topics: Aged; Contrast Media; Female; Fluorescein Angiography; Fluorocarbons; Humans; Retinal Hemorrhage; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity | 2000 |
Retinal detachment after pneumatic displacement for subfoveal hemorrhage.
Topics: Adult; Female; Fluorescein Angiography; Fluorocarbons; Humans; Injections; Postoperative Complications; Retinal Detachment; Retinal Hemorrhage; Tissue Plasminogen Activator; Visual Acuity; Vitrectomy | 2001 |
Success and complications of pneumatic retinopexy.
Topics: Adult; Aged; Aged, 80 and over; Cryosurgery; Female; Fluorocarbons; Gases; Humans; Male; Middle Aged; Postoperative Complications; Retinal Detachment; Retinal Hemorrhage; Retinal Perforations | 1988 |